1. Home
  2. VIVS vs MARPS Comparison

VIVS vs MARPS Comparison

Compare VIVS & MARPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIVS
  • MARPS
  • Stock Information
  • Founded
  • VIVS 2007
  • MARPS 1956
  • Country
  • VIVS United States
  • MARPS United States
  • Employees
  • VIVS N/A
  • MARPS N/A
  • Industry
  • VIVS Biotechnology: Biological Products (No Diagnostic Substances)
  • MARPS Oil & Gas Production
  • Sector
  • VIVS Health Care
  • MARPS Energy
  • Exchange
  • VIVS Nasdaq
  • MARPS Nasdaq
  • Market Cap
  • VIVS 8.1M
  • MARPS 9.1M
  • IPO Year
  • VIVS N/A
  • MARPS N/A
  • Fundamental
  • Price
  • VIVS $2.28
  • MARPS $4.78
  • Analyst Decision
  • VIVS
  • MARPS
  • Analyst Count
  • VIVS 0
  • MARPS 0
  • Target Price
  • VIVS N/A
  • MARPS N/A
  • AVG Volume (30 Days)
  • VIVS 104.1K
  • MARPS 16.3K
  • Earning Date
  • VIVS 11-12-2025
  • MARPS 01-01-0001
  • Dividend Yield
  • VIVS N/A
  • MARPS 7.51%
  • EPS Growth
  • VIVS N/A
  • MARPS 2.08
  • EPS
  • VIVS N/A
  • MARPS 0.36
  • Revenue
  • VIVS $142,000.00
  • MARPS $1,043,830.00
  • Revenue This Year
  • VIVS $42.38
  • MARPS N/A
  • Revenue Next Year
  • VIVS $15.42
  • MARPS N/A
  • P/E Ratio
  • VIVS N/A
  • MARPS $13.13
  • Revenue Growth
  • VIVS 94.52
  • MARPS N/A
  • 52 Week Low
  • VIVS $1.41
  • MARPS $3.34
  • 52 Week High
  • VIVS $21.96
  • MARPS $7.90
  • Technical
  • Relative Strength Index (RSI)
  • VIVS 38.84
  • MARPS 50.29
  • Support Level
  • VIVS $2.14
  • MARPS $4.50
  • Resistance Level
  • VIVS $2.44
  • MARPS $5.46
  • Average True Range (ATR)
  • VIVS 0.27
  • MARPS 0.21
  • MACD
  • VIVS -0.09
  • MARPS 0.04
  • Stochastic Oscillator
  • VIVS 10.00
  • MARPS 34.32

About VIVS VivoSim Labs Inc. Common Stock

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

About MARPS Marine Petroleum Trust Units of Beneficial Interest

Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.

Share on Social Networks: